Health Search On This Blog

Follow by Email

Fighting cancer with computer-designed nano-medicines

Personalized cancer medicine has advanced from a distant hope to a clinical reality. Oncologists regularly individualize treatments to target a tumor’s unique genetic weaknesses. But because these personalized medicines reach healthy tissues and tumors alike, even the most targeted treatments can cause unwanted side-effects.
A new approach devised by nanotechnology experts at the Sloan Kettering Institute (SKI) at Memorial Sloan Kettering Cancer Center may improve the precision of personalized medicines by helping them avoid collateral damage. “We found a way to use machine-learning algorithms to design powerful nanomedicines that can deliver a stronger, safer, more personalized punch,” says Daniel Heller, PhD, a chemist in the molecular pharmacology program at SKI and an assistant professor at the Weill Cornell Graduate School of Medical Sciences.
Heller’s laboratory designs nanotechnologies that improve the detection and treatment of cancer. Their computer-aided method allows nearly any class of personalized drug to be packaged into a nanoparticle, an approach that could help make these drugs safer and more effective.

Particle Man: Memorial Sloan Kettering chemist Daniel Heller, PhD, with 3-D-printed models of his cancer-fighting nanoparticles. Credit: Memorial Sloan Kettering

ShareThis